Ann: Bell Potter Healthcare Conference Presentation, page-2

Well at least Starpharma officially confirms via an ASX announcement that AstraZeneca and Chase Sun have left the building completely ... finally even though some of us have been trying to tell posters that for a while now and of course the focus is now on DEP® Radiotheranostics


Something else important to note on page 17 - It appears Starpharma have extended the original '9 months' guidance to secure a DEP® license deal by another 12 months ... you can't make this stuff up


Catalysts to Anticipate in The Next 12 Months

1. 1) License / collaboration for a DEP® asset to commercialise


Looking more and more like no one is interested in our DEP® drugs if we need to push out the guidance to secure a license by another 9 months on top of the original 9 month timeline issued earlier this year ?